Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmablast | 4 studies | 29% ± 16% | |
| transit amplifying cell | 4 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 30% ± 13% | |
| erythrocyte | 4 studies | 28% ± 9% | |
| CD4-positive, alpha-beta T cell | 4 studies | 32% ± 3% | |
| plasma cell | 3 studies | 24% ± 4% | |
| erythroblast | 3 studies | 34% ± 12% | |
| CD8-positive, alpha-beta T cell | 3 studies | 26% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 28% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 98% | 2599.49 | 1780 / 1809 | 97% | 78.90 | 460 / 472 |
| ovary | 94% | 289.56 | 170 / 180 | 99% | 84.65 | 425 / 430 |
| uterus | 94% | 234.33 | 159 / 170 | 99% | 146.91 | 454 / 459 |
| bladder | 95% | 210.19 | 20 / 21 | 96% | 108.58 | 486 / 504 |
| breast | 88% | 243.47 | 404 / 459 | 97% | 80.16 | 1084 / 1118 |
| intestine | 86% | 601.38 | 832 / 966 | 97% | 110.23 | 512 / 527 |
| stomach | 81% | 502.45 | 289 / 359 | 98% | 91.06 | 280 / 286 |
| esophagus | 72% | 918.77 | 1036 / 1445 | 99% | 82.19 | 181 / 183 |
| lung | 75% | 286.23 | 433 / 578 | 91% | 75.56 | 1047 / 1155 |
| thymus | 100% | 413.03 | 652 / 653 | 65% | 27.05 | 391 / 605 |
| pancreas | 58% | 107.86 | 190 / 328 | 76% | 34.90 | 135 / 178 |
| brain | 86% | 302.93 | 2267 / 2642 | 44% | 29.54 | 307 / 705 |
| adrenal gland | 93% | 344.60 | 240 / 258 | 32% | 19.68 | 74 / 230 |
| prostate | 88% | 195.95 | 215 / 245 | 35% | 10.33 | 177 / 502 |
| kidney | 88% | 286.71 | 78 / 89 | 25% | 8.72 | 226 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 144.10 | 29 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 170.59 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 32.95 | 1 / 1 |
| spleen | 100% | 770.32 | 240 / 241 | 0% | 0 | 0 / 0 |
| adipose | 83% | 198.69 | 1002 / 1204 | 0% | 0 | 0 / 0 |
| liver | 23% | 112.88 | 51 / 226 | 56% | 25.94 | 227 / 406 |
| peripheral blood | 64% | 1939.55 | 595 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 49% | 12.76 | 39 / 80 |
| blood vessel | 46% | 84.88 | 610 / 1335 | 0% | 0 | 0 / 0 |
| heart | 35% | 67.40 | 299 / 861 | 0% | 0 | 0 / 0 |
| muscle | 30% | 50.29 | 242 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
| GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0007052 | Biological process | mitotic spindle organization |
| GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_0051301 | Biological process | cell division |
| GO_0051987 | Biological process | positive regulation of attachment of spindle microtubules to kinetochore |
| GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
| GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
| GO_1905448 | Biological process | positive regulation of mitochondrial ATP synthesis coupled electron transport |
| GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
| GO_0090266 | Biological process | regulation of mitotic cell cycle spindle assembly checkpoint |
| GO_0044772 | Biological process | mitotic cell cycle phase transition |
| GO_0000922 | Cellular component | spindle pole |
| GO_0016020 | Cellular component | membrane |
| GO_0005813 | Cellular component | centrosome |
| GO_0097125 | Cellular component | cyclin B1-CDK1 complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000940 | Cellular component | outer kinetochore |
| GO_0005634 | Cellular component | nucleus |
| GO_0061575 | Molecular function | cyclin-dependent protein serine/threonine kinase activator activity |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
| GO_0005113 | Molecular function | patched binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
| Gene name | CCNB1 |
| Protein name | G2/mitotic-specific cyclin-B1 Cyclin B1 |
| Synonyms | CCNB |
| Description | FUNCTION: Essential for the control of the cell cycle at the G2/M (mitosis) transition. . FUNCTION: Essential for the control of the cell cycle at the G2/M (mitosis) transition. . |
| Accessions | ENST00000505500.5 [P14635-2] ENST00000507798.1 ENST00000508407.5 ENST00000256442.10 [P14635-1] E9PC90 H0Y9U8 ENST00000506572.5 H0YA62 D6RHI0 P14635 ENST00000503507.1 |
